Table 2. Comparison of treatment-adjusted prevalence of HIV infection in the adult population aged 15–49 years in western Kenya, Malawi, South Sudan and Zimbabwe, 2019.
| Variable | Western Kenya | Kenya | Malawi | South Sudan | Zimbabwe |
|---|---|---|---|---|---|
| Total population, extrapolateda | 3 858 268 | 30 888 800 | 11 235 955 | 7 320 000 | 9 921 875 |
| No. of people living with HIVb | 490 000 | 1 390 000 | 1 000 000 | 183 000 | 1 270 000 |
| Population HIV prevalence, %b | 12.7 | 4.5 | 8.9 | 2.5 | 12.8 |
| No. of people receiving ARTb | 367 000 | 1 042 164 | 784 948 | 33 253 | 1 014 039 |
| Treatment coverage, %c | 74.9 | 75.0 | 78.5 | 18.2 | 79.8 |
| Total population not receiving ARTd | 3 491 268 | 29 846 636 | 10 451 007 | 7 286 747 | 8 907 836 |
| No. of people living with HIV not receiving ARTe | 123 000 | 347 836 | 215 052 | 149 747 | 255 961 |
| Treatment-adjusted prevalence, %f | 3.5 | 1.2 | 2.1 | 2.1 | 2.9 |
ART: antiretroviral therapy; HIV: human immunodeficiency virus; UNAIDS: Joint United Nations Programme on HIV/AIDS.
a Derived by extrapolation from UNAIDS estimates of number of adults living with HIV and adult prevalence of HIV.7,8
c Calculated from number of adults receiving ART as a proportion of number of adults living with HIV.
d Calculated by subtracting number of people receiving ART from total population.
e Calculated by subtracting number of people receiving ART from number of people living with HIV.
f Calculated from number of people living with HIV not receiving ART as a percentage of total population not receiving ART.